Schneider Joel Solomon Zev 4
4 · Solid Biosciences Inc. · Filed Mar 15, 2022
Insider Transaction Report
Form 4
Schneider Joel Solomon Zev
Chief Operating Officer
Transactions
- Sale
Common Stock
[F1][F2]2022-03-14$1.10/sh−15,232$16,755→ 251,542 total - Sale
Common Stock
[F1]2022-03-14$1.10/sh−15,272$16,799→ 236,270 total
Footnotes (2)
- [F1]This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
- [F2]Reflects a correction as to the number of securities previously reported in Column 5 of Table I due to an arithmetical error.
Signature
/s/ Erin P. Brennan as attorney-in-fact for Joel Solomon Zev Schneider|2022-03-15